Rosalind Candelaria
Overview
Explore the profile of Rosalind Candelaria including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lim B, Seth S, Yam C, Huo L, Fujii T, Lee J, et al.
Cell Rep Med
. 2024 Jun;
5(6):101595.
PMID: 38838676
Luminal androgen receptor (LAR)-enriched triple-negative breast cancer (TNBC) is a distinct subtype. The efficacy of AR inhibitors and the relevant biomarkers in neoadjuvant therapy (NAT) are yet to be determined....
2.
Chen H, Ding Q, Khazai L, Zhao L, Damodaran S, Litton J, et al.
Ther Adv Med Oncol
. 2023 Aug;
15:17588359231189422.
PMID: 37547448
Background: Recent advances have been made in targeting the phosphoinositide 3-kinase pathway in breast cancer. Phosphatase and tensin homolog (PTEN) is a key component of that pathway. Objective: To understand...
3.
Abuhadra N, Sun R, Yam C, Rauch G, Ding Q, Lim B, et al.
Cancers (Basel)
. 2023 Jul;
15(13).
PMID: 37444385
High stromal tumor-infiltrating lymphocytes (sTILs) are associated with improved pathologic complete response (pCR) in triple-negative breast cancer (TNBC). We hypothesize that integrating high sTILs and additional clinicopathologic features associated with...
4.
Echeverria G, Cai S, Tu Y, Shao J, Powell E, Redwood A, et al.
NPJ Breast Cancer
. 2023 Jan;
9(1):2.
PMID: 36627285
Patient-derived xenograft (PDX) models of breast cancer are an effective discovery platform and tool for preclinical pharmacologic testing and biomarker identification. We established orthotopic PDX models of triple negative breast...
5.
Irajizad E, Wu R, Vykoukal J, Murage E, Spencer R, Dennison J, et al.
Front Artif Intell
. 2022 Aug;
5:876100.
PMID: 36034598
There is a need to identify biomarkers predictive of response to neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC). We previously obtained evidence that a polyamine signature in the blood...
6.
Abuhadra N, Sun R, Litton J, Rauch G, Yam C, Chang J, et al.
Cancers (Basel)
. 2022 Mar;
14(5).
PMID: 35267631
High stromal tumor-infiltrating lymphocytes (sTILs) are associated with an improved pathologic complete response (pCR) and survival in triple-negative breast cancer (TNBC). We hypothesized that high baseline sTILs would have a...
7.
Bragg A, Candelaria R, Adrada B, Huang M, Rauch G, Santiago L, et al.
J Clin Imaging Sci
. 2021 Jul;
11:34.
PMID: 34221643
Ductal carcinoma (DCIS) is a commonly encountered malignancy, accounting for approximately 20% of new breast cancer diagnoses in the United States. DCIS is characterized by a proliferation of tumor cells...
8.
Adrada B, Candelaria R, Moulder S, Thompson A, Wei P, Whitman G, et al.
Cancer
. 2021 Apr;
127(16):2880-2887.
PMID: 33878210
Background: Heterogeneity exists in the response of triple-negative breast cancer (TNBC) to standard anthracycline (AC)/taxane-based neoadjuvant systemic therapy (NAST), with 40% to 50% of patients having a pathologic complete response...
9.
Guirguis M, Adrada B, Santiago L, Candelaria R, Arribas E
Insights Imaging
. 2021 Apr;
12(1):53.
PMID: 33877461
Many benign breast entities have a clinical and imaging presentation that can mimic breast cancer. The purpose of this review is to illustrate the wide spectrum of imaging features that...
10.
Park K, Weiss A, Rosso K, Yi M, Hunt K, Kuerer H, et al.
Ann Surg Oncol
. 2019 Aug;
27(2):367-372.
PMID: 31399819
Background: There is limited data evaluating mastectomy skin flap complications of nipple-sparing mastectomy (NSM) in patients with BRCA gene mutations. The purpose of this study was to identify factors associated...